Literature DB >> 15057044

Loss of vascular adhesion protein-1 expression in intratumoral microvessels of human skin melanoma.

Csaba Forster-Horváth1, Balázs Döme, Sándor Paku, Andrea Ladányi, Beáta Somlai, Sirpa Jalkanen, József Tímár.   

Abstract

Intratumoral vessels are different both structurally and phenotypically, and this may have clinical significance. In this study we analysed the expression of an adhesion molecule--vascular adhesion protein-1 (VAP-1)--in melanoma-associated blood vessels in 28 primary skin melanoma cases using immunocytochemistry and immunoelectron microscopy. We have found that VAP-1 protein expression is significantly decreased in intratumoral vessels compared with peritumoral ones; this difference was independent of the tumour thickness. Loss of VAP-1 protein expression occurred in both endothelial and smooth muscle cell components. Unlike in other cancer types, the VAP-1 protein expression of intratumoral vessels did not correlate with the density of cytotoxic T-lymphocytes or dendritic cells. On the other hand, the 5-year survival of melanoma patients with low VAP-1 protein expression in intratumoral blood vessels (< or =25%) was lower (26.3%) than in patients whose VAP-1 expression was higher (42.6%, P=0.0632). These results support the idea that the phenotype of intratumoral blood vessels is important in the progression of malignant melanoma.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15057044     DOI: 10.1097/00008390-200404000-00010

Source DB:  PubMed          Journal:  Melanoma Res        ISSN: 0960-8931            Impact factor:   3.599


  9 in total

1.  68Ga-DOTA-E[c(RGDfK)]2 PET Imaging of SHARPIN-Regulated Integrin Activity in Mice.

Authors:  Riikka Siitonen; Emilia Peuhu; Anu Autio; Heidi Liljenbäck; Elina Mattila; Olli Metsälä; Meeri Käkelä; Tiina Saanijoki; Ingrid Dijkgraaf; Sirpa Jalkanen; Johanna Ivaska; Anne Roivainen
Journal:  J Nucl Med       Date:  2019-03-08       Impact factor: 10.057

2.  Association of microvessel density with infiltrating cells in human cutaneous malignant melanoma.

Authors:  Judit Kiss; József Tímár; Beáta Somlai; Katalin Gilde; Zsuzsanna Fejôs; István Gaudi; Andrea Ladányi
Journal:  Pathol Oncol Res       Date:  2007-03-27       Impact factor: 3.201

Review 3.  Hepatic consequences of vascular adhesion protein-1 expression.

Authors:  Chris J Weston; David H Adams
Journal:  J Neural Transm (Vienna)       Date:  2011-04-22       Impact factor: 3.575

4.  Serum vascular adhesion protein-1 predicts 10-year cardiovascular and cancer mortality in individuals with type 2 diabetes.

Authors:  Hung-Yuan Li; Yi-Der Jiang; Tien-Jyun Chang; Jung-Nan Wei; Mao-Shin Lin; Cheng-Hsin Lin; Fu-Tien Chiang; Shyang-Rong Shih; Chi Sheng Hung; Cyue-Huei Hua; David J Smith; Jani Vanio; Lee-Ming Chuang
Journal:  Diabetes       Date:  2011-01-31       Impact factor: 9.461

5.  Evaluation of serum and tissue levels of VAP-1 in colorectal cancer.

Authors:  Stephen T Ward; Christopher J Weston; Emma L Shepherd; Rahul Hejmadi; Tariq Ismail; David H Adams
Journal:  BMC Cancer       Date:  2016-02-24       Impact factor: 4.430

Review 6.  T-lymphocyte homing: an underappreciated yet critical hurdle for successful cancer immunotherapy.

Authors:  Robert Sackstein; Tobias Schatton; Steven R Barthel
Journal:  Lab Invest       Date:  2017-03-27       Impact factor: 5.662

7.  Inhibition of vascular adhesion protein-1 enhances the anti-tumor effects of immune checkpoint inhibitors.

Authors:  Tomonari Kinoshita; Mohammad Abu Sayem; Tomonori Yaguchi; Budiman Kharma; Kenji Morii; Daiki Kato; Shigeki Ohta; Yukihiko Mashima; Hisao Asamura; Yutaka Kawakami
Journal:  Cancer Sci       Date:  2021-03-18       Impact factor: 6.716

8.  [68Ga]Ga-DOTA-Siglec-9 Detects Pharmacodynamic Changes of FAP-Targeted IL2 Variant Immunotherapy in B16-FAP Melanoma Mice.

Authors:  Riikka Viitanen; Helena Virtanen; Heidi Liljenbäck; Olli Moisio; Xiang-Guo Li; Valeria Nicolini; Marine Richard; Christian Klein; Tapan Nayak; Sirpa Jalkanen; Anne Roivainen
Journal:  Front Immunol       Date:  2022-07-06       Impact factor: 8.786

9.  Vascular adhesion protein 1 in the eye.

Authors:  Wenting Luo; Fang Xie; Zhongyu Zhang; Dawei Sun
Journal:  J Ophthalmol       Date:  2013-06-04       Impact factor: 1.909

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.